Doctors from the Sydney Children's Hospital and the children's hospital at Westmead have developed a new test which can assess the presence of even small levels of leukemia in children's bone marrow.
In the event of cancer cells being detected, patients can begin the treatment early to improve the outcome.
A 10-year study into the efficacy of such tests showed that the survival rates improved from 35 per cent to 70 per cent in cases of acute lymphoblastic leukaemia.
Professor Glenn Marshall from the Sydney Children's Hospital at Randwick has said that this is a crucial step in improvement of personalized cancer care. The test also enables a report of children who are in the high risk category of relapse, therefore treatment can improve their chances of survival.